Free Trial

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Shares Sold by Deutsche Bank AG

Sabra Health Care REIT logo with Finance background

Deutsche Bank AG lowered its holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 32.4% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,086,792 shares of the real estate investment trust's stock after selling 998,506 shares during the period. Deutsche Bank AG owned approximately 0.88% of Sabra Health Care REIT worth $36,143,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in SBRA. Barclays PLC grew its holdings in Sabra Health Care REIT by 56.1% during the 3rd quarter. Barclays PLC now owns 678,397 shares of the real estate investment trust's stock worth $12,624,000 after acquiring an additional 243,895 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in Sabra Health Care REIT by 13.0% during the 4th quarter. Bank of New York Mellon Corp now owns 4,039,651 shares of the real estate investment trust's stock worth $69,967,000 after acquiring an additional 463,601 shares in the last quarter. abrdn plc grew its holdings in Sabra Health Care REIT by 2.9% during the 4th quarter. abrdn plc now owns 900,690 shares of the real estate investment trust's stock worth $15,600,000 after acquiring an additional 25,195 shares in the last quarter. ExodusPoint Capital Management LP grew its holdings in Sabra Health Care REIT by 66.9% during the 4th quarter. ExodusPoint Capital Management LP now owns 917,166 shares of the real estate investment trust's stock worth $15,885,000 after acquiring an additional 367,777 shares in the last quarter. Finally, Columbus Macro LLC acquired a new position in Sabra Health Care REIT during the 4th quarter worth approximately $5,729,000. Institutional investors and hedge funds own 99.40% of the company's stock.

Analyst Ratings Changes

Several research firms have commented on SBRA. Truist Financial boosted their price target on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "hold" rating in a report on Tuesday, March 18th. Scotiabank boosted their price target on shares of Sabra Health Care REIT from $18.00 to $19.00 and gave the stock a "sector perform" rating in a report on Monday, May 12th. Three equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $19.50.

Get Our Latest Analysis on SBRA

Sabra Health Care REIT Stock Up 0.6%

Shares of Sabra Health Care REIT stock traded up $0.11 during trading hours on Friday, hitting $17.87. The company had a trading volume of 2,663,446 shares, compared to its average volume of 2,176,119. The company's 50-day moving average is $17.49 and its two-hundred day moving average is $17.44. Sabra Health Care REIT, Inc. has a twelve month low of $13.87 and a twelve month high of $20.03. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16. The company has a market cap of $4.25 billion, a P/E ratio of 33.72, a price-to-earnings-growth ratio of 1.97 and a beta of 0.88.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last issued its earnings results on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.01. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. The business had revenue of $183.54 million during the quarter, compared to analysts' expectations of $180.23 million. During the same quarter in the prior year, the business posted $0.35 EPS. The company's revenue for the quarter was up 10.1% on a year-over-year basis. Analysts anticipate that Sabra Health Care REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 30th. Investors of record on Friday, May 16th will be paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 6.72%. The ex-dividend date of this dividend is Friday, May 16th. Sabra Health Care REIT's dividend payout ratio is currently 203.39%.

About Sabra Health Care REIT

(Free Report)

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Featured Stories

Institutional Ownership by Quarter for Sabra Health Care REIT (NASDAQ:SBRA)

Should You Invest $1,000 in Sabra Health Care REIT Right Now?

Before you consider Sabra Health Care REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.

While Sabra Health Care REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

New AI Deals Just Sent These 4 Infrastructure Stocks Soaring
7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines